WebMay 3, 2024 · Biochemical recurrence develops in almost one-third of men with prostate cancer after treatment with local therapy. There are numerous options for management, including surveillance, salvage radiation, androgen deprivation therapy (ADT), and clinical trials. This article reviews the current approaches to radiation therapy, ADT, and … WebAug 12, 2024 · Median metastasis-free survival (MFS) was 144 months and 192 months from the time of local treatment in men with a PSA doubling time of less than 6 months and less than 10 months, respectively ...

Recent Advances in the Management of Metastatic Prostate Cancer

Web2 days ago · Docetaxel plus ADT should be offered to patients with metastatic noncastrate prostate cancer with high-volume disease (four or more bone metastases, one or more … WebADT for locally advanced cancer may be used after a radical prostatectomy or with radiation therapy. It may also be given to help control advanced prostate cancer. There are … assarih tunisie

Radiotherapy with or without androgen deprivation therapy in ...

WebOct 8, 2024 · Testosterone stimulates the growth of prostate cancer, the most common nonskin cancer diagnosed in men. (2) ADT is used to lower serum testosterone to a … WebApr 7, 2024 · Prostate cancer is categorized into four stages that indicate severity and spread. Stages 1 and 2 are known as localized or early-stage cancer; stage 3 is called … WebAug 24, 2024 · These findings led to the development of androgen deprivation therapy (ADT) as the treatment for patients with advanced prostate cancer. Although ADT is palliative, it can normalize serum levels of prostate-specific antigen in over 90 percent of patients and can produce objective tumor responses in 80 to 90 percent. assarih tunisie sport